Markets
Black Hawk Acquisition Corporation (BKHA)
BKHANASDAQ-GMBiotechnology: Biological Products (No Diagnostic Substances)
$7.20
-0.0999 (-1.37%) today
At the close, Nov 16, 4:00 PM ET. After hours $7.30 +1.38%
-1.37% 1D
- Market cap
- –
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $6.58 to $7.44
- 52-week range
- $3.70 to $23.00
- Average volume
- –
- Previous close
- $7.30
Financials
| Quarter | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$218.0k | -$54.0k | -$109.0k | -$138.0k |
| Net income | -$4,000 | $140.0k | $89.0k | $1.07m |
News
8 latest- Stock Indexes Retreat as Chipmakers and AI Stocks FallBarchart · 5 minutes ago
- Weakness in Chipmakers and AI Stocks Weighs on Stock IndexesBarchart · 12 minutes ago
- See Which Recent 13F Filers Hold MRKBNK Invest · 13 minutes ago
- Walmart Inc. Appoints Joseph E. Creed to Board of DirectorsFintel · 14 minutes ago
- Galectin Therapeutics Inc. Reports September 30, 2026 Financial Results and $105.8 million Debt ConversionFintel · 14 minutes ago
- Is Nu Holdings Stock a Buy, Sell, or Hold After Falling 24% in 2026?The Motley Fool · 16 minutes ago
- Could Anthropic’s IPO Reverse the Market’s Sentiment on AI?The Motley Fool · 18 minutes ago
- Franklin Covey: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 20 minutes ago
The company
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- bhspac.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.